FDA approval of 23andMe’s genetic test positive sign for the genomics industry

On February 19, the Food and Drug Administration approved a test made by 23andMe, the Mountain View, Calif.-based personal genetics company, for a gene that can cause a rare disorder called Bloom Syndrome, which causes short stature and a heightened risk of cancer.

This is news not because a new carrier test is important, but because the FDA seems to be using this test as a way to start to think out its plans for regulating new types of genetic tests that are emerging from the revolution in DNA sequencing, the technology that can read out a person’s genetic material at a materials cost of less than $1,000. The news is a positive not only for 23andMe but also for Illumina, the largest maker of DNA sequencing gear, and smaller players like Thermo-Fisher, PacBio, and Oxford Nanopore.

The big question is how the FDA will regulate cases where doctor’s want to sequence all of a patient’s genes, or whole genome sequencing. It is meeting today (February 20) to collect advice from scientists.

The reason the 23andMe approval is exciting is that it represents a baby step into this world. It doesn’t put 23andMe back into the business of selling consumers lots of genetic tests (it will take time even for the company to launch a test that does carrier screening) but it makes it easier to imagine a world where the FDA intelligently regulates genetic data.

Read full, original article: What 23andMe’s FDA Approval Means For The Future Of Genomics

 

 

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.